Our Investigational Drug Services Special Interest Group is a community of pharmacists who specialize in coordination, oversight, & management of investigational drugs for #cancer#clinical trials.
Read our@AJHPOfficial recently-published manuscript: https://t.co/zZeO2B6U1t
@OpusOneWinery Perfect night to bust out the 2013 Opus, fire's burning, great company, waiting on Santa. Truly best wine we've ever had! Merry Christmas!
Historically, phase 1 trials have been aimed at defining the toxic effects of an agent. With the advent of targeted therapies and immunotherapies, response rates in 224 phase 1 trials reported from January 1, 2014, through June 30, 2015, were nearly 20%. https://t.co/0Fm6uvxhpx
Accelerated infusion rate of daratumumab (20% of the dose over 30 minutes and 80% over 60 minutes) in patients who have received 2 prior doses at standard infusion rates. Standard practice at Ohio State. #mmsm#ash17 https://t.co/ihZRAnuvNE